Article | July 17, 2026

Good AI Practice In GxP: 4 Implications Of FDA/EMA's Joint AI Principles

AI, digital innovation-GettyImages-2202490582

Clear guardrails from global regulatory agencies have redefined the expectations for integrating artificial intelligence (AI) within good manufacturing practice (GMP) environments. No longer viewed as pilot projects or IT experiments, AI-driven systems influencing manufacturing, calibration, or maintenance decisions must meet the same validation, lifecycle monitoring, and data integrity standards as any other GxP system. Designing a compliant program demands an explicit context of use, proportional risk-tiered validation, and strict data governance that treats training inputs with raw-material-level care. True compliance also requires ongoing drift monitoring to protect against silent performance degradation over time. Review the practical, regulatory-aligned playbook for managing the validation lifecycle, tackling hidden data governance risks, and eradicating shadow AI to ensure audit readiness. Explore how to safely realize the power of operational AI.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online